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ackground: Mutations in gene coding for hepatocyte growth factor protein, HGF are responsible for 
hereditary deafness worldwide. Evaluation of recurrent variations displays prevalent heredity diversity of 
a specific population. Mutational screening of HGF was aimed to ascertain the causative recurrent 
variations in Kashmiri families. 
Methods: Kashmiri families were enrolled from different divisions of Azad Jammu and Kashmir. By employing 
linkage analysis all the families were screened for loci common in Pakistani population. Families linked with 
DFNB39 locus were subjected to direct sequencing for mutational analysis of variants prevalent in Pakistani 
population.  
Results: Sanger sequencing identified a noncoding c.482+1986_1988delTGA variant of HGF as recurrent 
mutation in Kashmiri population. These findings implicate this HGF variant as major contributing variant of 
hearing impairment in Kashmiri families with a frequency of 8.8%. 
Conclusion: This is the first study conducted to elucidate the founder effect and prevalence of HGF variants in 
Kashmiri population. This study increases the prevalence of HGF variants associated with hearing impairment 
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Hearing impairment (HI) is a heterogeneous infirmity 
worldwide. In Pakistan incidence of bilateral HI is 1.6 per 
1000 individuals [1-3]. The Kashmiri population of 
Pakistan is an invaluable resource to study the recessive 
mode of genetic disorders like HI due to high incidence 
rates of consanguineous marriages or mating within the 
same ethnic groups [4-6]. The hearing loss related gene 
mutation patterns vary significantly among different 
races and regions. In Kashmiri population almost 70% of 
the HI appears due to consanguineous reunions, 
consequently as compared to other populations of the 
world, the number of hearing impaired families in this 
population is much higher [7]. 
Deafness is caused by hundreds of genes that when 
get mutated cause pathogenicity [8-12]. Of the 93 non-
syndromic hearing deafness (NSHD) loci that recorded 
so far, the pathogenic variations have been known for 75 
genes (Hereditary Hearing Loss Homepage: 
https://hereditaryhearingloss.org/). This varies from 
cochlear specialized genes performing inner ear specific 
functions to housekeeping genes with ubiquitous 
expression [13,14]. For many monogenic disorders 
extensive genetic analysis studies have presented 
variations in noncoding part of the genes. One such 
gene, hepatocyte growth factor gene HGF has been 
reported to cause non syndromic deafness in large 
cohort of hearing impaired families due to variations 
present in noncoding region of the gene [15]. 
Human hereditary deafness (DFNB39) is concomitant 
with noncoding variations in the 3'UTR and intron of an 
isoform of HGF. The growth factors like hepatocyte 
growth factors (HGF) are essential for the development 
of auditory system and for the maintenance of hearing 
process in humans. In many different tissues this growth 
factor is involved to perform intricate signal transduction 
mechanism. Mouse model studies revealed abnormal 
cochlear tissue growth in inner ear in the absence of 
HGF. HGF is essential for integration of sensory crest 
cells into the central stria vascularis layer during the 
development of inner ear of mice. The stria retains an 
endocochlear potential (+80 to +120 mV) and high 
potassium concentration necessary for 
mechanotransduction of sound by inner hair cells of ear 
[16]. Using a HGF mutant mouse in a study [15] with a 
ten base pair deletion recapitulating a 
human DFNB39 noncoding variant. The findings of the 
study demonstrated failure of migration of neural crest 
cells to stria vascularis middle layer causing significant 
reduced endocochlear potential in inner ear hair cells. 
Regulatory putative HGF variants have been reported 
to cause surprisingly a specific phenotype, non-
syndromic deafness. HGF levels must be fine-tuned for 
normal hearing as an over or less HGF expression 
results in loss of hearing. In this study we identified one 
regulatory variant (c.482+1986_1988delTGA) in the non-
coding region (intron 4) of the HGF as recurrent mutation 
in four Kashmiri families of Pakistan.     
Methods 
An approval from Institutional Review Board was 
obtained for this study from National Centre of 
Excellence in Molecular Biology, University of the Punjab 
Lahore Pakistan. A total of 45 families with three or more 
affected individuals were visited and collected from 
different divisions of Azad Jammu and Kashmir region of 
Pakistan. Pedigrees were constructed for the 
confirmation of inheritance pattern and initial medical 
information. Detailed medical histories were recorded to 
rule out environmental factors and any associated 
syndromes.10 ml of blood sample was taken from all the 
participants of the study. Blood samples were preserved 
at -20 ºC for long term storage before DNA extraction. 
Extraction and Quantification of Genomic DNA 
For the extraction of DNA standard protocol of DNA 
extraction was performed [17]. The integrity and 
quantification of DNA was estimated by using Agarose 
gel electrophoresis.  
Screening of Common Deafness Loci 
Linkage analysis was performed initially for all the 
families to screen common prevalent deafness loci 
(DFNB1, DFNB2, DFNB3, DFNB4, DFNB12 and 
DFNB39) by using STR markers (fluorescently labeled). 
The pooled PCR products were evaluated on 3130 DNA 
genetic analyzer. Gene mapper software was used for 
allele calling. Cyrillic software was used for constructing 
pedigrees and Haplotypes. LOD (logarithm of odds) 
score was calculated by FASTLINK [18]. 
Mutational Screening 
PCR (polymerase chain reaction) amplification following 
Sanger sequencing was done for one primer pair of HGF 
with most common non coding mutation in intron 4 (Table 
1). The sequencing results were analyzed with 
Sequencher® 5.4.6 software (Gene Codes Corporation). 
Primer 
Name 












Table 1: Primer Sequences for Amplification of HGF Intron 4. 
Results 
In the present study four consanguineous Kashmiri 
kindred, Family1563, Family1577, Family1587 and 
Family1589 with hearing impairment, were linked to 
DFNB39 locus with recurrent noncoding mutation in 
intron 4 of HGF. The families belonged to same ethnic 
(Kashmiri) background and caste (Jutt). Autosomal 
recessive inheritance pattern was found in all the four 
families (Figure 1). No affected individual from four 
families had complaint of night blindness or any other 
clinical manifestation. The haplotype of all hearing 
impaired individuals of families showed linkage to 
DFNB39 locus at chromosome 7q21.11. In Family1563 
a maximum two point LOD score (Zmax) of 2.10 at θ= 0 
was observed with marker D7S660 and D7S2540. 
Linkage was sustained to this region at distal (D7S660) 
and proximal side (D7S2540) for other three families with 
maximum two point LOD score (Zmax) of 2.19 (with 
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Figure 1: Pedigrees of Family1563 (a), Family1577 (b), Family1587 (c) and Family1589 (d) with the haplotypes of alleles on 
chromosome 7q21.11 and segregation of c.482+1986_1988delTGA HGF variant. Alleles forming the risk haplotype are shaded black 
and alleles not co-segregating with HL are shown in white. Square: male; circle: female; filled symbol: affected individual; the double 
line between individuals: consanguineous marriage; diagonal line through a symbol: deceased individual. 
 
Figure 2: Sequence chromatograms of mutations identified in 
patients with HL. (A) Chromatogram of affected individuals 
homozygous for c.482+1986_1988delTGA mutation in HGF; (B) 
unaffected individual homozygous for wild type allele. (C) 
Heterozygous carriers for c.482+1986_1988delTGA in HGF. 
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markers D7S660, D7S806 and D7S2540), 2.83 (with 
markers D7S806 and D7S2540) and 2.68 (with markers 
D7S660 and D7S2540) at θ= 0 for Family 1577, Family 
1587 and Family 1589 respectively (Table 2). Zmax was 
obtained with D7S2540 in all four families. The 
assembled haplotype also displayed same genotype 
pattern i.e., 184, 132 and 190 (Table 3) for all the four 
families revealing founder effect. 
Bidirectional Sanger sequencing revealed that all the 
four families harbored common recurrent 
c.482+1986_1988delTGA mutation in intron 4 of HGF. 
All the affected individuals showed homozygosity for the 
identified mutation.  Intronic noncoding three base pair 

















































a result of which protein features might be affected. 
Consequently, the genetic expression of 
c.482+1986_1988delTGA relates to the phenotypic 
manifestation of hereditary deafness in all four families. 
The damaging effects of this noncoding mutation 
were verified by using different in silico tools i.e., 
Mutation Taster, ExAC (exome aggregation consortium), 
LRT (likelihood ratio test), EVS (exome variant server), 
TGP (1000 genome project) and GERP (genomic 
evolutionary rate profiling) score (Table 3). The variant 
was classified as disease causing according to Mutation 
Taster. The occurrence of same causative pathogenic 
mutation (c.482+1986_1988delTGA) in all ethnically 
matched families inhabiting Kashmir region pave the 
Family Markers cM Mb 0 0.01 0.03 0.05 0.07 0.09 0.1 0.2 0.3 Zmax θmax 
 
Family1563 
D7S660 93.63 80.59 2.10 1.55 1.94 1.83 1.72 1.61 1.55 1.00 0.49 2.10 0 
D7S806 94.87 81.36 2.18 1.68 2.03 1.95 1.83 1.73 1.68 1.16 0.65 2.18 0 
D7S2540 97.38 83.11 2.10 1.59 1.95 1.85 1.74 1.64 1.59 1.06 0.55 2.10 0 
 
Family1577 
D7S660 93.63 80.59 2.19 2.14 2.06 1.97 89 1.80 1.75 1.27 0.78 2.19 0 
D7S806 94.87 81.36 2.19 2.14 2.06 1.97 89 1.80 1.75 1.27 0.78 2.19 0 
D7S2540 97.38 83.11 2.19 2.14 2.06 1.97 89 1.80 1.75 1.27 0.78 2.19 0 
Family1587 D7S660 93.63 80.59 2.06 2.00 1.90 1.80 1.70 1.59 1.54 1.02 0.53 2.06 0 
D7S806 94.87 81.36 2.83 2.78 2.67 2.56 2.44 2.33 2.27 1.66 1.04 2.83 0 
D7S2540 97.38 83.11 2.83 2.78 2.66 2.54 2.42 2.29 2.23 1.60 0.97 2.83 0 
Family1589 D7S660 93.63 80.59 2.68 2.63 2.53 2.42 2.32 2.21 2.16 1.61 1.04 2.68 0 
D7S806 94.87 81.36 2.49 2.44 2.34 2.24 2.13 2.03 1.97 1.42 0.85 2.49 0 
D7S2540 97.38 83.11 2.68 2.63 2.53 2.42 2.32 2.21 2.16 1.61 1.04 2.68 0 
Table 2: Two-point LOD scores localized to chromosome 7q21.11. 
Family 
Designation 
Ethnicity Cast STR haplotypes linked to DFNB39 Variant In silico tools 
D7S660 D7S806 D7S2540 
Family1563 Kashmiri Jutt 184 132 190 Δ3 Mutation Taster EVS 
Frequency 
EXAC TGP LRT GERP 
Score 
Family1577 Kashmiri Jutt 184 132 190 Δ3 Splice site 
changes/Disease 
causing 
Absent Absent Absent Absent Absent 
Family1587 Kashmiri Jutt 184 132 190 Δ3 
Family1589 Kashmiri Jutt 184 132 190 Δ3 
Δ3=c.482+1986_1988delTGA 
Table 3: STR Haplotype Linked To DFNB39 And In Silico Validation. 
Family rs1421134578 rs904221567 rs1371361043 rs1208755637 B39 rs1296475387 rs1030487619 rs1464051447 rs963677172 
Family1577 GG CC TT GG Δ3 GG TT TT CC 
Family1587 GG CC TT CC Δ3 GG TT TT CC 
Family1589 GG CC TT CC Δ3 GG TT TT CC 
Family1563 GG CC TT CC Δ3 GG TT TT CC 
SNP Single nucleotide polymorphism 
Δ3=c.482+1986_1988delTGA 
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mode to probe the founder effect of pathogenic 
noncoding mutation among these four Kashmiri families 
belonging to Jutt caste. All normal wild type bases 
flanking the detected mutation were assembled where 
established haplotype around site of mutation revealed 
the common founder effect of c.482+1986_1988delTGA 
mutation (Table 4).  
Discussion 
In current study noncoding c.482+1986_1988delTGA 
HGF variant is reported in four consanguineous Kashmiri 
families with NSHD (non-syndromic hereditary 
deafness). The families were linked to DFNB39 locus at 
chromosome 7q21.11. Linkage was persistent to this 
region at distal (D7S660) and proximal side (D7S2540) 
with Zmax obtained with D7S2540 in all four families. 
The findings were consistent with the work of [15] 
ascertaining three base pair deletion in intron 4 
(c.482+1986_1988delTGA) in thirty six Pakistani and two 
Indian families suffering from hearing loss.  For this 
deletion mutation heterozygosity was detected in 2 out of 
429 control samples of Pakistani population. While none 
of control sample out of 830 Indian, Caucasian, and 
human diversity panel control chromosomes revealed 
heterozygous genetic status for the same mutation. This 
noncoding deletion mutation vested in a region of 
putative splice enhancer sites (exonic) contiguous to an 
anticipated binding site of splice factor. The findings of 
present and previous study propose that the deletion 
might result in dysregulation of HGF isoforms [19]. 
All four families with same ethnicity and caste linked to 
DFNB39 locus presented same alleles haplotype 
strongly predicted this variant sharing common ancestral 
inheritance. Inconstant incidence of recurring variations 
in genes has been studied among ethnically diverse 
groups [20]. Three mutations (non-coding) in HGF have 
been reported in Pakistani and Indian population 
resulting in non-syndromic deafness. The two non-
coding HGF variants in intron 4 were 
c.482+1986_1988delTGA and 
c.482+1991_2000delGATGATGAAA. The 3rd was 
c.495G>A; p.S165S synonymous splice site variant 
present in exon 5 [15]. In the present study, four out of 
forty five families suffering from hearing loss had non- 
coding deletion mutation, c.482+1986_1988delTGA, 
estimating 8.8% frequency of HGF variation in Kashmiri 
population which is in line with the previous study 
describing same frequency of HGF variation in a study 
on Pakistani families [21]. 
Our study encapsulates the genetic mutational 
spectrum concluding founder effect of detected HGF 
non-coding variation among hearing impaired families 
from Azad Jammu and Kashmir region of Pakistan. 
Increasing the screening of such variants will lessen 
disease burden and will further sweep the way of 
diagnostic therapeutics. This study outlines the 
mutational spectrum of HGF in Kashmiri population first 
time. 
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